A patient-led initiative for rare disease hereditary haemorrhagic telangiectasia (HHT) has won the inaugural Prix Galien ...
Dojolvi was approved in the US in 2020 and was also launched in Japan earlier this year. Ultragenyx recorded sales of $45 ...
Hutchmed and AstraZeneca's Orpathys is now under review in Europe and Japan for MET-driven, EGFR-mutated lung cancer, a few ...
On 3 and 4 December 2026, Florence will host ISMAI 2026, the International Symposium on Medical AI, organised by the ...
Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid) has been granted an accelerated approval by the FDA as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results